พบ "Public health policy"ทั้งหมด 1,303 ผลลัพธ์
เรียงลำดับตาม
ความเกี่ยวข้อง

Development of reference case for economic evaluation on precision medicine for health insurance reimbursement in Thailand

The rapidly evolving healthcare landscape is being shaped by cutting-edge technologies such as big data analytics, digital advancements, and genomics, leading to the emergence of Precision Medicine (PM). National genomics programs worldwide are embracing PM\'s potential, signaling an imminent integration into healthcare systems. However, PM interve

Advanced health biotechnologies in Thailand: State of the art, future trends and strategic preparation

Aiming at appropriate preparation for the future development of individualized and regenerative medicine (in particular, gene, stem cell and tissue engineering therapies), the Health Intervention and Technology Assessment (HITAP) program has agreed to conduct a study to provide an insight on elements necessary for national policymaking in Thailand.

Priority-Setting Institutions in Health: Recommendations from a Center for Global Development Working Group. (2012)

Priority-Setting Institutions in Health: Recommendations from a Center for Global Development Working Group. Amanda Glassmanemail, Kalipso Chalkidou, Ursula Giedion, Yot Teerawattananon, Sean Tunis, Jesse B. Bump, Andres Pichon-Riviere Abstract The rationing problem is common to all health

Health technology assessments as a mechanism for increased value for money: recommendations to the Global Fund (2013)

Health technology assessments as a mechanism for increased value for money: recommendations to the Global Fund. Yot Teerawattananon1*, Kate McQueston2, Amanda Glassman2, Jomkwan Yothasamut1,2 and Chaw Yin Myint1,2 Abstract The Global Fund is experiencing increased pressure to optimize resul

Measurement properties of the EQ-5D-5L compared to EQ-5D-3L in the Thai diabetes patients (2015)

Juntana Pattanaphesaj and Montarat Thavorncharoensap Abstract Background: The EQ-5D is a health-related quality of life instrument which provides a simple descriptive health profile and a single index value for health status. The latest version, the EQ-5D-5L, has been translated into morethan

Health Technology Assessment: Global Advocacy and Local Realities

Abstract Cost-effectiveness analysis (CEA) can help countries attain and sustain universal health coverage (UHC), as long as it is context-specific and considered within deliberative processes at the country level. Institutionalising robust deliberative processes requires significant time and res

A landscape analysis of health technology assessment capacity in the Association of South-East Asian Nations region

Abstract Background Progress towards achieving Universal Health Coverage and institutionalizing healthcare priority setting through health technology assessment (HTA) in the Association of South-East Asian Nations (ASEAN) region varies considerably across countries because of differences in heal

Health economic evaluations for Indonesia: a systematic review assessing evidence quality and adherence to the Indonesian Health Technology Assessment (HTA) Guideline

The Government of Indonesia implemented health technology assessment (HTA) to ensure quality and cost control in the National Health Insurance Program (Jaminan Kesehatan Nasional/JKN). The current aim of the study was to improve the usefulness of future economic evaluation for resource allocation by

Early health technology assessment of tongue swab for non-sputum based pulmonary tuberculosis diagnosis in Thailand

Background Sputum-based diagnostic methods for pulmonary tuberculosis (PTB) are challenging for patients who cannot produce sputum. Non-sputum-based approaches, such as tongue swab (TS), can address this gap. This study conducts an early Health Technology Assessment (HTA) of TS for PTB diagnosi

Good Practices for Health Technology Assessment Guideline Development: A Report of the Health Technology Assessment International, HTAsiaLink, and ISPOR Special Task Force

Highlights This report provides practical guidance for developing or updating health technology assessment (HTA) guidelines, especially in low- and middle-income countries where HTA is increasingly used as a priority setting tool for healthcare resource allocation and achieving universa
10 / หน้า